Glasgow Precision Oncology Laboratory

Turning scientific discoveries into precision medicine for cancer

By working with researchers and industry we develop, apply and test precision medicine strategies based on genomic sequencing data.

Home of the Glasgow Cancer Assays, the Glasgow Precision Oncology Laboratory‘s purpose-built facilities, expertise and resources are aligned to maximise the speed of development of novel precision strategies in oncology.


Medical Genomics


Glasgow Cancer Assays


Therapeutic Development


Clinical Implementation

Latest News View All News

GPOL to provide genomic sequencing for mesothelioma

GPOL will provide genomic sequencing for the University of Glasgow-led PREDICT-Meso (Pre-malignant drivers combined with target-drug validation in mesothelioma), a new £5 million mesothelioma project…


About Us

GPOL was established in 2016 to enable precision oncology from discovery right through to clinical trials.

Read more

Research Team

Our researchers are working on cancer science that really matters in the real world.


The GPOL is a purpose-built molecular profiling unit specifically designed to address the needs for large-scale discovery alongside the development, and delivery, of clinically relevant assays.

Our Collaborations

GPOL supports clinical trials, scientific research and precision medicine delivery.


Precision medicine requires the integration of a molecular pathology driven approach throughout the therapeutic development cycle.


Join our team

We are looking for highly motivated and innovative individuals to join our team of pioneering researchers.

Join The Team